Thrombocytopenia: Causes, Types, and Nursing Management

Thrombocytopenia is a common hematologic problem on nursing exams, and recognizing the different types — especially ITP, HIT, and TTP — is critical because each has a unique cause, presentation, and treatment. This guide reviews definitions, causes, clinical findings, diagnostics, and nursing priorities.

What Is Thrombocytopenia?

• Thrombocytopenia is a platelet count below 150,000/microliter.
• Spontaneous bleeding occurs when platelets drop below 20,000/microliter.

Causes — PLATELETS Mnemonic

• P — Platelet disorders: Immune thrombocytopenia (ITP) and thrombotic thrombocytopenic purpura (TTP).
• L — Leukemia: Bone marrow infiltration by malignant cells.
• A — Aplastic anemia: Bone marrow failure reduces platelet production.
• T — Trauma: Massive blood loss and dilution from transfusions.
• E — Enlarged spleen: Hypersplenism traps platelets.
• L — Liver disease: Cirrhosis → portal hypertension → splenomegaly.
• E — Ethanol: Alcohol suppresses bone marrow platelet production.
• T — Toxicity: Heparin (HIT), chemotherapy, aspirin, NSAIDs.
• S — Sepsis: Disseminated intravascular coagulation (DIC) consumes platelets.

Severity and Clinical Presentation

• Mild (50,000–150,000): Usually asymptomatic; bleeding may occur with trauma or surgery.
• Moderate (20,000–50,000): Easy bruising, petechiae, and prolonged bleeding from minor cuts.
• Severe (below 20,000): Spontaneous epistaxis, gingival bleeding, and menorrhagia.
• Life-threatening (below 10,000): High risk of intracranial hemorrhage and GI bleeding.
• Petechiae: Small, flat, red or purple spots from bleeding into the skin.
• Purpura: Larger areas of bruising without trauma.

Immune Thrombocytopenia (ITP)

• Autoimmune disorder in which antibodies destroy platelets in the spleen.
• Most common cause of isolated thrombocytopenia; PT/INR and PTT are normal.
• First-line: Corticosteroids (e.g., prednisone).
• IVIG for severe bleeding or before surgery.
• Splenectomy for chronic, refractory cases.
• Thrombopoietin receptor agonists (romiplostim, eltrombopag) stimulate platelet production.

Heparin-Induced Thrombocytopenia (HIT)

• Immune reaction to heparin causing platelet destruction and paradoxical thrombosis.
• Causes clots, not bleeding; occurs 5–10 days after heparin exposure.
• Platelet count drops by 50% or falls below 150,000.
• Medical emergency — increased risk of venous and arterial clots.
• Stop all heparin products immediately and start a direct thrombin inhibitor such as argatroban.
• Warfarin is contraindicated in acute HIT — risk of skin necrosis.
• Transition to warfarin only after platelets recover above 150,000.
• Document heparin allergy in the patient's record.

Thrombotic Thrombocytopenic Purpura (TTP)

• Life-threatening disorder caused by deficiency of the ADAMTS13 enzyme.
• Large von Willebrand factor multimers cause platelet clumping.
• Classic pentad: thrombocytopenia, microangiopathic hemolytic anemia, neurologic symptoms, renal failure, and fever.
• Treatment: Plasma exchange (plasmapheresis) and corticosteroids.

Diagnostic Tests

• CBC confirms low platelet count.
• Peripheral blood smear rules out pseudothrombocytopenia from platelet clumping.
• PT/INR and PTT are normal in isolated thrombocytopenia (rules out coagulopathy).
• HIT antibody test confirms HIT; ADAMTS13 activity is low in TTP.

General Management

• Identify and treat the underlying cause.
• Avoid NSAIDs and aspirin (increase bleeding risk).
• Avoid intramuscular injections (can cause hematomas).
• Use a soft toothbrush and electric razor.
• Administer stool softeners to prevent straining.
• Platelet transfusion is indicated for active bleeding or before invasive procedures when platelets are below 50,000.
• Platelet transfusion is generally not indicated for ITP or HIT unless life-threatening bleeding occurs.

Nursing Assessment and Interventions

• Monitor for petechiae, purpura, and ecchymosis.
• Assess for bleeding: nosebleeds, gum bleeding, hematuria, melena, or heavy menses.
• Monitor neurologic status — headache or confusion may indicate intracranial bleeding.
• For HIT, assess for thrombosis: leg swelling/pain, dyspnea, chest pain.
• Apply pressure to puncture sites for 5–10 minutes after injections or blood draws.
• Implement fall precautions.

Patient Teaching

• Avoid NSAIDs, aspirin, and contact sports.
• Use a soft toothbrush and electric razor.
• Report bleeding, severe headache, or confusion immediately.
• For HIT, inform all healthcare providers of the heparin allergy.

Common Exam Traps

• ITP: isolated thrombocytopenia with normal PT/INR and PTT.
• HIT: thrombocytopenia with paradoxical thrombosis, not bleeding.
• HIT occurs 5–10 days after heparin exposure — stop all heparin immediately.
• Platelet transfusion is generally not indicated for ITP or HIT.
• Spontaneous bleeding occurs when platelets drop below 20,000.
• Warfarin is contraindicated in acute HIT due to risk of skin necrosis.
• TTP pentad: thrombocytopenia, hemolytic anemia, neurologic changes, renal failure, fever.

Key takeaways

• Thrombocytopenia = platelets <150,000; spontaneous bleeding risk <20,000; intracranial hemorrhage risk <10,000.
• ITP → autoimmune; treat with corticosteroids, IVIG, or splenectomy.
• HIT → clots (not bleeding) 5–10 days after heparin; stop heparin and start argatroban; avoid warfarin acutely.
• TTP → pentad of thrombocytopenia, hemolytic anemia, neuro symptoms, renal failure, fever; treat with plasma exchange.
• Avoid NSAIDs, aspirin, and IM injections; use soft toothbrush, electric razor, and stool softeners.
• Nursing priorities: monitor for bleeding, prevent injury, and teach bleeding precautions.